stockportfolio.pro
Pfizer Inc. Free Cash Flow 2007–2025
Pfizer Inc. (PFE) annual free cash flow by fiscal year, computed from SEC filings. Compound growth -1.3%/yr over 18 years.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $9.07B | -7.7% |
| FY 2024 | $9.84B | +105.2% |
| FY 2023 | $4.79B | -81.6% |
| FY 2022 | $26.03B | -12.8% |
| FY 2021 | $29.87B | +145.3% |
| FY 2020 | $12.18B | +15.5% |
| FY 2019 | $10.54B | -23.8% |
| FY 2018 | $13.84B | -6.8% |
| FY 2017 | $14.85B | +3.3% |
| FY 2016 | $14.37B | +8.1% |
| FY 2015 | $13.29B | -16.3% |
| FY 2014 | $15.88B | -3.6% |
| FY 2013 | $16.48B | +6.9% |
| FY 2012 | $15.42B | -17.0% |
| FY 2011 | $18.58B | +86.9% |
| FY 2010 | $9.94B | -35.4% |
| FY 2009 | $15.38B | -7.0% |
| FY 2008 | $16.54B | +44.1% |
| FY 2007 | $11.47B | — |
Source: Pfizer Inc. SEC filings — cash flow statement (10-K). Refreshed nightly.
See the full picture for Pfizer Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePfizer Inc. — frequently asked questions
What is Pfizer Inc.'s free cash flow?
Pfizer Inc. (PFE) reported free cash flow of $9.07B for fiscal year 2025, per its SEC filings.
How has Pfizer Inc.'s free cash flow changed over time?
Between fiscal 2007 and 2025, PFE's free cash flow declined at roughly 1.3% per year (compound annual rate), from $11.47B to $9.07B.
Where does this data come from?
Figures are computed from Pfizer Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.